ENZ Financial Facts

Loss before income taxes: -5.85M
Royalty and license fee income: 1.01M
See Full Income Statement

Prepaid expenses: 2.21M
Total liabilities and stockholders’ equity: 62.23M
See Full Balance Sheet

Earnings History for Enzo Biochem (ENZ)

  |   Expand Research on ENZ
Next EPS Date 6/7/13 *Est. EPS Growth Rate -250.0% *Last Qtr.
Average EPS % Beat Rate -1.6% Revenue Growth Rate -11.2% *Last Qtr.
Average % Move 1-Wk after EPS -14.2%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
12/10/12 Q113 -$0.09N/A N/A $15.18M$14.19M N/A / N/A N/A -16.7% Details
10/15/12 Q412 -$0.69N/A N/A $26.4M$26.8M N/A / N/A N/A +9.8% Details
3/12/13 Q213 -$0.14N/A N/A $22.2M$25M N/A / N/A N/A -22.8% Details
3/12/12 Q212 -$0.04N/A N/A $25M$23.7M N/A / N/A N/A -20.3% Details
6/9/11 Q311 -$0.05-$0.11 +$0.06$25.8M$24.77M N/A / N/A N/A -39.6% Details
10/14/10 Q410 -$0.10-$0.09 -$0.01N/AN/A N/A / N/A N/A -47.7% Details
12/12/11 Q112 -$0.12-$0.08 -$0.04$25.75M$27.04M N/A / N/A N/A -5.9% Details
6/11/12 Q312 -$0.09N/A N/A $26M$25.8M N/A / N/A N/A +17.3% Details